Table 2. Clinical characterization of seven patients who achieved HBsAg seroconversion at 24 weeks, and seven age/sex/HBsAg level at baseline -matched NR cases.
| Patient ID | Age | Sex | ALT | HBsAg | 1sttime point achieved seroconversion | |
|---|---|---|---|---|---|---|
| R (n = 7) | 1 | 32 | M | 32 | 239.3 | 24W |
| 2 | 39 | M | 29 | 0.693 | 24W | |
| 3 | 39 | M | 35 | 2.85 | 24W | |
| 4 | 17 | F | 33 | 0.326 | 24W | |
| 5 | 40 | F | 31 | 13.56 | 24W | |
| 6 | 32 | F | 30 | 85 | 24W | |
| 7 | 41 | M | 28 | 70 | 24W | |
| NR (n = 7) | 1 | 38 | M | 28 | 230.4 | NA |
| 2 | 35 | M | 29 | 1.424 | NA | |
| 3 | 40 | M | 31 | 6.7 | NA | |
| 4 | 20 | F | 34 | 0.592 | NA | |
| 5 | 36 | F | 29 | 12.9 | NA | |
| 6 | 32 | M | 30 | 89.4 | NA | |
| 7 | 40 | F | 34 | 78 | NA |
NA = not achived.